# S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

> **NCT00017147** · PHASE3 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 183 (actual)

## Conditions studied

- Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System

## Interventions

- **DRUG:** carmustine
- **RADIATION:** radiation therapy
- **DRUG:** O6-Benzylguanine

## Key facts

- **NCT ID:** NCT00017147
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2006-05
- **Final completion:** 2012-11
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2013-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017147, "S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00017147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*